Collegium Pharmaceutical
COLL
#6620
Rank
โ‚ฌ0.73 B
Marketcap
23,63ย โ‚ฌ
Share price
1.49%
Change (1 day)
-39.64%
Change (1 year)

Earnings for Collegium Pharmaceutical (COLL)

Earnings in 2026 (TTM): โ‚ฌ0.10 Billion

According to Collegium Pharmaceutical 's latest financial reports the company's current earnings are โ‚ฌ0.81 Billion. In 2025 the company made an earning of โ‚ฌ0.15 Billion, an increase over its 2024 earnings that were of โ‚ฌ0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Collegium Pharmaceutical from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ0.10 B-35.62%
2025 โ‚ฌ0.15 B1.38%
2024 โ‚ฌ0.15 B8.47%
2023 โ‚ฌ0.14 B362.88%
2022 โ‚ฌ31.31 M94.82%
2021 โ‚ฌ16.07 M-68.76%
2020 โ‚ฌ51.45 M-358.85%
2019 -โ‚ฌ19.88 Million14.82%
2018 -โ‚ฌ17.32 Million-74.68%
2017 -โ‚ฌ68.39 Million-20.23%
2016 -โ‚ฌ85.74 Million250.85%
2015 -โ‚ฌ24.44 Million51.81%
2014 -โ‚ฌ16.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
United Therapeutics
UTHR
โ‚ฌ1.38 B 1,179.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
-โ‚ฌ13.7 Million-112.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
โ‚ฌ0.46 B 331.56%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
KemPharm
KMPH
-โ‚ฌ38.19 Million-135.28%๐Ÿ‡บ๐Ÿ‡ธ USA